Accueil > Revues > Médecine > European Journal of Dermatology > Texte intégral de l'article
 
      Recherche avancée    Panier    English version 
 
Nouveautés
Catalogue/Recherche
Collections
Toutes les revues
Médecine
European Journal of Dermatology
- Numéro en cours
- Archives
- S'abonner
- Commander un       numéro
- Plus d'infos
Biologie et recherche
Santé publique
Agronomie et Biotech.
Mon compte
Mot de passe oublié ?
Activer mon compte
S'abonner
Licences IP
- Mode d'emploi
- Demande de devis
- Contrat de licence
Commander un numéro
Articles à la carte
Newsletters
Publier chez JLE
Revues
Ouvrages
Espace annonceurs
Droits étrangers
Diffuseurs



 

Texte intégral de l'article
 
  Version imprimable
  Version PDF

Measuring the impact of oral mucosa disease on quality of life


European Journal of Dermatology. Volume 19, Numéro 6, 603-6, November-December 2009, Clinical report

DOI : 10.1684/ejd.2009.0762

Summary  

Auteur(s) : Pía López-Jornet, Fabio Camacho-Alonso, Mayra Lucero Berdugo , Clínica Odontológica Universitaria. Medicina Bucal, Hospital Morales Meseguer. Adv. Marques de los Velez s/n, Murcia 30008, Spain.

ARTICLE

Auteur(s) : Pía López-Jornet, Fabio Camacho-Alonso, Mayra Lucero Berdugo

Clínica Odontológica Universitaria. Medicina Bucal , Hospital Morales Meseguer. Adv. Marques de los Velez s/n, Murcia 30008, Spain

accepté le 30 Mai 2009

According to the World Health Organization (WHO), quality of life (QOL) is defined as an individual’s perception of his position in life in the context of the culture and value system in which he lives and in relation to his goals, expectations and standards and concerns [1]. While the ‘‘health-related quality of life’’ is usually defined in relation to health and physical function, emotional well-being, general health perception and social function [2], oral health-related QOL (OHQoL) characterizes a person’s perception of how oral health influences an individual’s quality of life and overall well-being [3-6].

Patients with oral mucosa diseases suffer from severe and life threatening symptoms, preventing them from eating and drinking, and influencing daily life in many ways. The importance of embracing patients’ views in assessing oral health needs and in treatment planning has been widely advocated. To that end a number of different patient-centered oral health status measures have been developed over the last decade, to assess the physical, social and psychological consequences of oral health, and thus the impact of oral health status on quality of life. These measures are suggested to complement traditional clinical oral health status, to improve communication between patients and their clinical attendants, and to provide greater understanding of the consequences of oral disease upon day to day living and quality of life [7, 8].

The Short-Form Survey 36 (SF-36) is a validated instrument, designed specifically to detect differences between individuals in a general population [9, 10]. The Oral Health Impact Profile (OHIP) questionnaire is designed to measure self-reported dysfunction, discomfort and disability attributed to oral conditions, and is based on a conceptual oral health model outlined by Locker [5, 6]. The original instrument has 49 items representing 7 domains (functional limitation, physical pain, psychological discomfort, physical disability, psychological disability, social disability, and handicap) and has been shown to be reliable, sensitive to changes, and to exhibit suitable cross-cultural consistency.

The Oral Health Impact Profile (OHIP-49) is one of the most commonly used instruments for evaluating oral health-related quality of life, and was developed for detailed measurement of the levels of dysfunction, discomfort and disability associated with oral disorders [11-13].

The concepts of general and oral health and QOL have become an integral part of health care research. Oral mucosa disorders include a vast group of dermatological diseases involving the mouth as well as oral changes reflecting non-pathological conditions [14, 15]. Oral mucosa diseases can also be part of a disease involving other sites. For example, lichen planus can remain limited to the oral mucosa or involve other mucosal membranes and the skin.

The oral QOL measures are limited principally to dental disease, hyposalivation, temporomandibular disorders and oral cancer [16-19]. Very few studies are available on oral mucosal diseases not related to the dental apparatus, such as oral lichen planus [20].

The aim of this study was to evaluate the general quality of life in patients with oral pathology using the Spanish validated SF-36 questionnaire, and to measure the oral quality of life using the OHIP-49 validated Spanish version.

Material and methods

Two hundred sixteen patients with pathologies of the oral mucosa were studied consecutively at the Oral Medicine Service of the University of Murcia between January 2006 and September 2008. This was an observational transversal study to evaluate the self-perceived Health-Related QOL in patients with oral mucosa pathology. All patients in the study were Caucasian, Spanish-speaking from the South-East of Spain.

The study was performed according to the principles of the Helsinki Declaration and was approved by the local ethics committee. The interviewer (previously trained) gave the patients detailed information about the study, as well as the expected length of the interview (30-40 minutes). The interview was carried out after receiving informed consent from the patient. The interview consisted of the SF-36 validated Spanish version [19] and the OHIP-49 validated Spanish version, which contains 49 items [11]. The subjects were asked about their symptoms in relation to the last month.

Inclusion criteria to participate in the study were: patients attending the Oral Medicine Service during the study period, aged over 18 years, diagnosed with burning mouth syndrome, oral lichen planus, recurrent aphthous stomatitis, and other mucosal diseases including 6 pemphigus vulgaris, 1 cicatricial pemphigoid, and 8 oral discoid lupus erythematous. Exclusion criteria were: not wishing to participate in the study, and patients with Behçet’s disease or with cutaneous manifestations of the diseases studied. To analyze the data, the diseases were grouped into different categories. The lesions were classified in accordance with established criteria and based on clinical examination, complementary studies (biopsy and immunofluorescence) and etiology. However, we are aware that the group denominated “others” includes very different diseases, its creation being necessary due to the small number of cases.

The SF-36 questionnaire is designed to evaluate the quality of life during the 4 weeks prior to the interview. The standard version of the Health Questionnaire SF-36 contains 8 areas [19]. “Physical functioning”, “Role limitations physical”, “Bodily pain”, “General medical health”, “Vitality”, “Social functioning”, “Role limitations emotional” and “Mental health”. The scoring system is designed in such a way that the higher scores indicate better health; thus, 0 is the worst state of health and 100 the ideal state of health.

The OHIP-49 focuses on measuring oral health. In this instrument, each item is scored: “never”-score 0, “hardly ever”-score 1, “occasionally”-score 2, “fairly often”-score 3, “very often”-score 4. The OHIP-49 is divided into 7 different domains, and the possible score range for each one is: “functional limitation” (9 items) - from 0 to 36; “physical pain” (9 items) - from 0 to 36; “psychological discomfort” (5 items) - from 0 to 20; “physical disability” (9 items) - from 0 to 36; “psychological disability” (6 items) - from 0 to 24; “social disability” (5 items) - from 0 to 20; “Handicap” (6 items) - from 0 to 24; and finally “Overall OHIP score” (49 items) - from 0 to 196. In this model, the higher scores indicate a poorer state of health.

Statistical analysis

Data were analyzed using the SPSS 12.0 statistics program (SPSS® Inc, Chicago, IL, USA). A descriptive study was made of each variable. The one-way ANOVA test was used to compare differences in the continuous variables. Probability for p ≤ 0.05 was accepted as significant.

Results

The study sample comprise 216 patients with a mean age of 56.63 ± 17.62, including 54 men (25%) and 162 women (75%). The patients were classified according to the oral pathology presented. The group with burning mouth syndrome (BMS) constituted 60 patients, 10 (6.7%) men and 50 (83.3%) women, mean age 64.10 ± 13.47, and minor recurrent aphthous stomatitis 41 patients, 20 men (48.8%) and 21 women (51.2%), mean age 35.05 ± 15.57. There were 100 patients diagnosed with oral lichen planus, 17 (17.0%) men and 83 (83.0%) women, mean age 60.45 ± 13.13, and finally 15 patients formed the group of other oral mucosa diseases, with a mean age of 60.20 ± 19.29, involving 7 (46.7%) men and 8 (53.3%) women.

With respect to the OHIP-49, we found significant differences between the groups in the sub-scales: physical disability, psychological disability, social disability and handicap, present the OHIP-49 all item 58.35 ± 43.98 in burning mouth syndrome (table 1). In the group formed by other mucosal diseases, the worst scores were obtained in the domains “physical pain” and “social disability”.

Regarding quality of life, table 2 illustrates the results for the SF-36 questionnaire between the different study groups, showing the significant differences found between the groups in each domain, except in the bodily pain. Patients with BMS had in general the lowest scores in the sub-scales of physical functioning, bodily pain, vitality, social functioning, emotional and mental health when compared with the other groups. The group formed by other mucosal lesions presented the lowest scores in the domains physical and general health.
Table 1 Oral health impact profile (OHIP-49) sub-scale and all items, by group (One-way ANOVA test)

OHIP-49 Dimensions

Burning mouth syndrome (n = 60)

Recurrent aphthous stomatitis (n = 41)

Oral lichen planus (n = 100)

Othter vesicular and bullous disorders* (n = 15)

p-value

Functional limitation

12.77 ± 8.11

8.63 ± 7.78

11.83 ± 7.65

11.73 ± 7.98

0.067

Physical pain

11.53 ± 8.92

8.83 ± 7.83

11.15 ± 7.39

11.93 ± 8.05

0.324

Psychological discomfort

6.22 ± 5.74

4.44 ± 6.48

4.62 ± 5.76

4.53 ± 3.50

0.315

Physical disability

11.62 ± 9.09

7.29 ± 7.74

9.12 ± 7.16

11.00 ± 7.48

0.043

Psychological disability

5.18 ± 5.96

1.66 ± 3.51

2.16 ± 3.51

4.20 ± 3.50

< 0.001

Social disability

3.75 ± 5.04

1.83 ± 5.43

1.65 ± 3.71

3.87 ± 4.79

0.018

Handicap

7.32 ± 6.21

2.68 ± 5.88

2.16 ± 4.24

4.33 ± 5.17

< 0.001

OHIP-49 (all items)

58.35 ± 43.98

35.05 ± 38.28

42.20 ± 32.61

51.60 ± 36.25

0.011


Table 2 Medical outcomes short form Health Survey Questionnaire (SF-36), by group (One-way ANOVA test)

SF-36 Dimensions

Burning mouth syndrome (n = 60)

Recurrent aphthous stomatitis (n = 41)

Oral lichen planus (n = 100)

Othter vesicular and bullous disorders* (n = 15)

p-value

Physical functioning

47.08 ± 36.91

96.17 ± 11.34

72.70 ± 30.55

66.00 ± 33.01

< 0.001

Role physical

29.33 ± 43.61

78.65 ± 40.91

46.50 ± 49.74

13.33± 35.18

< 0.001

Bodily pain

55.05 ± 27.47

72.50 ± 21.85

62.97 ± 24.66

58.83 ± 25.35

0.008

General health

37.49 ± 26.52

72.84 ± 18.44

52.02 ± 27.54

36.66± 31.07

< 0.001

Vitality

42.58 ± 24.93

65.31 ± 15.31

51.20 ± 20.89

48.66 ± 17.67

< 0.001

Social functioning

58.75 ± 27.55

88.71 ± 16.00

71.65 ± 22.23

63.33 ± 25.20

<0.001

Role emotional

42.77 ± 47.17

86.99 ± 31.51

51.99 ± 49.30

60.00 ± 50.70

< 0.001

Mental health

53.03 ± 26.05

74.79 ± 15.77

55.37 ± 18.31

57.60 ± 10.56

< 0.001

Discussion

Based on the existing literature, oral health problems can result in pain and discomfort and can lead to problems in eating, interpersonal relationships, appearance and an individual’s positive self-image [21, 22].

This study investigated the impact of oral mucosa disease on patients’ quality of life. The measures employed in this study were chosen because they have been widely used internationally, and both are validated Spanish versions. This study demonstrates that routine evaluation during clinical activity is feasible, and provides relevant and useful information for the clinical management of patients with oral mucosa pathology. Although until recently the use of measurement instruments has been limited to clinical trials and other research programs, their use is now recommended for the clinical diagnosis and follow-up of the patients. These instruments must be simple and practical enough for clinicians and patients to use and interpret [11-13, 21].

Using the SF-36 and OHIP-49 health-related quality of life instruments, aiming to compare with other conditions and with the general population, showed that the impact of burning mouth syndrome on quality of life is surprising, there is a drastic reduction in quality of life. Llewellyn and Warnakulasuriya [20] evaluated stomatological diseases (keratosis, ulcers, lichen planus, candidiasis, dry mouth, burning mouth, temporomandibular disorders and pain) using the OHIP-14, finding that diseases of the oral mucosa can have a serious impact on the patients’ oral quality of life.

Hegarthy et al. [2] found that increase in pain evaluated by VAS score was associated with poor oral health-related quality of life in patients with lichen planus. Pain is an important factor in limiting oral and other everyday functions in patients. Tambolli S et al. in 2009 [10] studied the quality of life and psychological problems in patients with oral mucosa disease, finding that oral mucosal conditions radically affected HRQoL and were accompanied by a very high frequency of psychological problems.

Mumcu et al. [23] observed worse oral health-related quality of life in patients with Behçet’s disease and recurrent aphthous stomatitis, and in patients with active oral ulcers compared with ulcer-free ones. In the present study, some disparate values were found in the SF-36 for the group recurrent aphthous stomatitis (RAS) in the domains physical functioning and general health, this disparity may be explained in part by the difference in mean age between the groups, being lower in the study group.

In recent years, there has been a growing interest in the assessment of quality of life (QoL), particularly in chronic disabling conditions [24, 25]. It is increasingly accepted that physical indicators of oral morbidity and the patient’s perception of oral conditions contribute to the description of oral health status. Both the objective part, which is accessible to the healthcare professional, and the subjective part, which is experienced by the patient, are complementary, not antagonistic. Like the two sides of a coin, they belong together and cannot be separated in clinical practice or research [8, 20].

The observation in one single time point during the course of these diseases is a substantial limitation of the study; being a transversal design, it is impossible to establish an unequivocal cause-effect relationship in the association between two factors. The next stage is to evaluate patients longitudinally for effectiveness of mucosal disease management and quality of life, and to evaluate the effectiveness of the incorporation of patient centered outcome measures into the clinical decision-making process.

Acknowledgements

Financial support: none. Conflict of interest: none.

References

1 Koller M, Klinkhammer-Schalke M, Lorenz W. Outcome and quality of life in medicine: a conceptual framework to put quality of life research into practice. Urologic Oncology 2005; 23: 186-92.

2 Hegarty AM, McGrath C, Hodgson TA, et al. Patient centered outcome measures in oral medicine: Are they valid and reliable? Int J Oral Maxillofacial Surg 2002; 31: 670-4.

3 Slade GD, Spencer A. Development and evaluation of the Oral Health Impact Profile. Community Dental Health 1994; 11: 3-11.

4 Slade GD. Assessing change in quality of life using the Oral Health Impact Profile. Community Dent Oral Epidemiol 1998; 26: 52-61.

5 Locker D. Measuring oral health: a conceptual framework. Community Dent Health 1988; 5: 3-18.

6 Locker D, Jokovic A, Clarke M. Assessing the responsiveness of measures of oral health-related quality of life. Community Dent Oral Epidemiol 2004; 32: 10-8.

7 Chren MM, Lasek RJ, Quinn LM, et al. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol 1996; 107: 707-13.

8 McGrath C, Hegarty AM, Hodgson TA, et al. Patient-centered outcome measures for oral mucosal disease are sensitive to treatment. Int J Oral Maxillofac Surg 2003; 32: 334-6.

9 Alonso J, Prieto L, Anto JM. The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): an instrument for measuring clinical results. Med Clin (Barc) 1995; 104: 771-6.

10 Tabolli S, Bergamo F, Alessandroni L, et al. Quality of Life and Psychological Problems of Patients with Oral Mucosal Disease in Dermatological Practice. Dermatology. 2009 Jan 28. Epub ahead of print

11 Lopez R, Baelum V. Spanish version of the Oral Health Impact Profile (OHIP-Sp). BMC Oral Health 2006; 6: 1-8.

12 Kieffer JM, Hoogstraten J. Item-order effects in the Oral Health Impact Profile (OHIP). Eur J Oral Sci 2008; 116: 245-9.

13 Kieffer JM, Hoogstraten J. Linking oral health, general health, and quality of life. Eur J Oral Sci 2008; 116: 445-50.

14 Tabolli S, Mozzetta A, Antinone V, et al. The health impact of pemphigus vulgaris and pemphigus foliaceus assessed using the Medical Outcomes Study 36-item short form health survey questionnaire. Br J Dermatol 2008; 158: 1029-34.

15 Tabolli S, Baliva G, Lombardo GA, et al. Health related quality of life assessment in the routine clinical practice of a dermatology unit. Eur J Dermatol 2006; 16: 409-15.

16 Lee S, McGrath C, Samman N. Quality of life in patients with dentofacial deformity: a comparison of measurement approaches. Int J Oral Maxillofac Surg 2007; 36: 488-92.

17 John MT, Reissmann DR, Schierz O, et al. Oral health-related quality of life in patients with temporomandibular disorders. J Orofac Pain 2007; 21: 46-54.

18 Baker SR, Pankhurst CL, Robinson PG. Utility of two oral health-related quality-of-life measures in patients with xerostomia. Community Dent Oral Epidemiol 2006; 34: 351-62.

19 Ikebe K, Matsuda K, Morii K, et al. Impact of dry mouth and hyposalivation on oral health-related quality of life of elderly Japanese. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103: 216-22.

20 Llewellyn CD, Warnakulasuriya S. The impact of stomatological disease on oral health-related quality of life. Eur J Oral Sci 2003; 111: 297-304.

21 López-Jornet P, Camacho-Alonso F, Lucero-Berdugo M. Quality of life in patients with burning mouth syndrome. J Oral Pathol Med 2008; 37: 389-94.

22 Soto Araya M, Rojas Alcayaga G, Esguep A. Association between psychological disorders and the presence of Oral lichen planus, Burning mouth syndrome and Recurrent aphthous stomatitis. Med Oral 2004; 9: 1-7.

23 Mumcu G, Inanc N, Ergun TI, et al. H. Oral health related quality of life is affected by disease activity in Behçet’s disease. Oral Dis 2006; 12: 145-51.

24 Tabolli S, Baliva G, Lombardo GA, et al. Health related quality of life assessment in the routine clinical practice of a dermatology unit. Eur J Dermatol 2006; 16: 409-15.

25 Gieler U. Psychodermatology. Eur J Dermatol 2007; 17: 106-7.


 

Qui sommes-nous ? - Contactez-nous - Conditions d'utilisation - Paiement sécurisé
Actualités - Les congrès
Copyright © 2007 John Libbey Eurotext - Tous droits réservés
[ Informations légales - Powered by Dolomède ]